JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 11 1922-1926
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parisi, M. T.
Right arrow Articles by Sandler, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parisi, M. T.
Right arrow Articles by Sandler, E. D.

Optimized Diagnostic Strategy for Neuroblastoma in Opsoclonus-Myoclonus

Marguerite T. Parisi, Robert S. Hattner, Katherine K. Matthay, Bruce O. Berg and E. Dayan Sandler

Departments of Radiology, Nuclear Medicine, Pediatrics and Neurology, University of California, San Francisco, California

Correspondence: For correspondence and reprints contact: M.T. Parisi, MD, Assistant Professor of Radiology and Pediatrics, Department of Radiology, Mailstop #81, Childrens Hospital Los Angeles, 4650 Sunset Blvd., Los Angeles, CA 90027.

ABSTRACT

Infantile myoclonic encephalopathy (opsoclonus-myoclonus or IME) is a rare clinical syndrome associated with occult neuroblastoma in 20%–50% of all cases. IME is the initial presentation of neuroblastoma in 1%–3% of children. Imaging approaches including chest radiography and abdominal computed tomography (CT) have been proposed to detect neuroblastoma in IME. Metaiodobenzylguanidine (MIBG) is highly effective in the detection of neuroblastoma. These scans can identify both soft-tissue and skeletal lesions anywhere in the body. Our purpose was to attempt to determine the best screening method for detection of occult neuroblastoma in patients with IME. Records of all neuroblastoma patients from 1983 to May 1991 were reviewed. Four cases of IME with neuroblastoma were identified in which imaging studies included an MIBG scan. All four patients had positive MIBG scans (100%) while only two had masses on initial CT (50%). In the three patients initially evaluated by traditional methods, the mean time to diagnosis and the mean number of advanced radiologic studies were 7.5 mo and 7.3 studies respectively. The patient screened with MIBG had only cranial and abdominal CT prior to surgery. Although based on a limited number of patients, results suggest that MIBG may prove to be a useful screening procedure in patients with IME. Traditional imaging modalities can then be directed to evaluate sites of disease identified by MIBG scans.




This article has been cited by other articles:


Home page
NEJMHome page
E.C. Engle and E.T. Hedley-Whyte
Case 27-1995- A 29-month-old girl with worsening ataxia, nystagmus, and subsequent opsoclonus and myoclonus
N. Engl. J. Med., August 31, 1995; 333(9): 579 - 586.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.